O'Brien Greene & Co. Inc Becton Dickinson & CO Transaction History

O'Brien Greene & Co. Inc

  • $306 Million
  • Q3 2025

A detailed history of O'Brien Greene & Co. Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 4,073 shares of BDX stock, worth $777,861. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,073
Previous 5,594 27.19%
Holding current value
$777,861
Previous $963,000 20.87%
% of portfolio
0.25%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
SELL
$172.41 - $199.66 $262,235 - $303,682
-1,521 Reduced 27.19%
4,073 $762,000
Q2 2025

Aug 06, 2025
SELL
$165.15 - $226.42 $51,857 - $71,095
-314 Reduced 5.31%
5,594 $963,000
Q1 2025

May 12, 2025
SELL
$222.79 - $249.08 $2,227 - $2,490
-10 Reduced 0.17%
5,908 $1.35 Million
Q4 2024

Feb 03, 2025
SELL
$220.02 - $243.75 $3.7 Million - $4.1 Million
-16,822 Reduced 73.98%
5,918 $1.34 Million
Q3 2024

Nov 15, 2024
SELL
$221.47 - $242.41 $341,063 - $373,311
-1,540 Reduced 6.34%
22,740 $5.48 Million
Q2 2024

Aug 12, 2024
BUY
$225.07 - $246.17 $89,352 - $97,729
397 Added 1.66%
24,280 $5.67 Million
Q1 2024

May 02, 2024
SELL
$233.45 - $247.73 $69,101 - $73,328
-296 Reduced 1.22%
23,883 $5.91 Million
Q4 2023

Feb 02, 2024
BUY
$232.24 - $267.23 $33,442 - $38,481
144 Added 0.6%
24,179 $5.9 Million
Q3 2023

Nov 08, 2023
BUY
$254.9 - $283.59 $33,646 - $37,433
132 Added 0.55%
24,035 $6.21 Million
Q2 2023

Aug 15, 2023
SELL
$238.39 - $265.32 $11.4 Million - $12.7 Million
-47,806 Reduced 66.67%
23,903 $6.31 Million
Q2 2023

Jul 20, 2023
BUY
$238.39 - $265.32 $11.4 Million - $12.7 Million
47,712 Added 198.82%
71,709 $18.9 Million
Q1 2023

May 03, 2023
BUY
$229.71 - $259.35 $22,511 - $25,416
98 Added 0.41%
23,997 $5.94 Million
Q4 2022

Feb 02, 2023
SELL
$218.29 - $256.91 $10.7 Million - $12.6 Million
-49,100 Reduced 67.26%
23,899 $6.08 Million
Q3 2022

Nov 09, 2022
BUY
$51.03 - $264.23 $2.51 Million - $13 Million
49,269 Added 207.62%
72,999 $16.3 Million
Q2 2022

Aug 11, 2022
BUY
$234.74 - $275.42 $125,585 - $147,349
535 Added 2.31%
23,730 $5.85 Million
Q1 2022

May 18, 2022
BUY
$243.64 - $270.48 $75,528 - $83,848
310 Added 1.35%
23,195 $6.17 Million
Q4 2021

Feb 08, 2022
BUY
$230.08 - $250.94 $136,207 - $148,556
592 Added 2.66%
22,885 $5.76 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $139,864 - $154,138
601 Added 2.77%
22,293 $5.48 Million
Q2 2021

Aug 09, 2021
BUY
$232.65 - $254.58 $296,861 - $324,844
1,276 Added 6.25%
21,692 $5.28 Million
Q1 2021

May 12, 2021
BUY
$232.09 - $256.88 $160,374 - $177,504
691 Added 3.5%
20,416 $4.96 Million
Q4 2020

Feb 04, 2021
BUY
$221.92 - $245.94 $16,644 - $18,445
75 Added 0.38%
19,725 $4.94 Million
Q3 2020

Nov 09, 2020
BUY
$215.77 - $276.76 $12,083 - $15,498
56 Added 0.29%
19,650 $4.57 Million
Q2 2020

Aug 10, 2020
BUY
$219.9 - $263.41 $92,358 - $110,632
420 Added 2.19%
19,594 $4.69 Million
Q1 2020

May 07, 2020
SELL
$195.69 - $279.01 $2,935 - $4,185
-15 Reduced 0.08%
19,174 $4.41 Million
Q4 2019

Feb 05, 2020
BUY
$236.45 - $266.82 $86,777 - $97,922
367 Added 1.95%
19,189 $5.22 Million
Q3 2019

Nov 07, 2019
BUY
$230.58 - $256.08 $23,519 - $26,120
102 Added 0.54%
18,822 $4.76 Million
Q2 2019

Aug 21, 2019
BUY
$217.4 - $246.08 $82,177 - $93,018
378 Added 2.06%
18,720 $4.72 Million
Q1 2019

Apr 29, 2019
BUY
$206.05 - $248.17 $646,997 - $779,253
3,140 Added 20.66%
18,342 $4.58 Million
Q4 2018

Feb 27, 2019
BUY
$204.73 - $257.93 $3.11 Million - $3.92 Million
15,202 New
15,202 $3.43 Million

Others Institutions Holding BDX

# of Institutions
1,723
Shares Held
257M
Call Options Held
1.07M
Put Options Held
551K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track O'Brien Greene & Co. Inc Portfolio

Follow O'Brien Greene & Co. Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Greene & Co. Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email